海创药业-U
(688302)
| 流通市值：37.95亿 | | | 总市值：46.10亿 |
| 流通股本：8151.51万 | | | 总股本：9901.56万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 201,109,921.11 | 633,443,935.77 | 488,047,263.3 | 533,440,653.77 |
| 预付款项 | 10,350,958.47 | 10,256,203.75 | 18,267,915.89 | 23,808,067.64 |
| 其他应收款合计 | 657,711.39 | 836,105.91 | 1,290,079.34 | 895,036.58 |
| 存货 | 935,654.36 | 4,557.13 | 165,214.48 | 146,948.09 |
| 一年内到期的非流动资产 | 106,820,000.01 | - | - | - |
| 其他流动资产 | 32,687,123.45 | 30,513,537.21 | 27,745,208.81 | 23,763,047.79 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 934,096,922.92 | 885,541,034.62 | 956,759,836.22 | 1,022,992,503.54 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 7,032,308.8 | 7,032,308.8 | 7,032,308.8 | 7,032,308.8 |
| 固定资产 | 5,821,277.16 | 5,439,862 | 4,608,070.86 | 5,007,640.81 |
| 在建工程 | 320,541,081.69 | 314,504,087.83 | 288,215,053.87 | 263,781,536.61 |
| 使用权资产 | 7,911,541.05 | 8,678,499.63 | 9,667,335.74 | 10,626,130.34 |
| 无形资产 | 30,344,938.4 | 30,560,916.6 | 30,723,186.96 | 30,885,457.32 |
| 长期待摊费用 | - | - | 10,308.26 | 20,616.35 |
| 其他非流动资产 | 4,124,591.71 | 109,823,078.95 | 107,721,922.54 | 104,837,993.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 375,775,738.81 | 476,038,753.81 | 447,978,187.03 | 422,191,683.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,309,872,661.73 | 1,361,579,788.43 | 1,404,738,023.25 | 1,445,184,186.91 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 108,778,749.52 | 131,635,318.64 | 134,276,587.14 | 126,586,441.52 |
| 其中：应付票据 | 18,511,825.77 | 34,765,430.66 | 49,075,285.63 | 36,601,769.31 |
| 应付账款 | 90,266,923.75 | 96,869,887.98 | 85,201,301.51 | 89,984,672.21 |
| 合同负债 | 4,716.98 | - | 212,601.77 | 164,601.77 |
| 应付职工薪酬 | 7,588,330.83 | 5,862,712.77 | 7,021,133.94 | 6,448,633.17 |
| 应交税费 | 638,735.8 | 1,228,247.84 | 1,203,364.98 | 1,071,204.61 |
| 其他应付款合计 | 4,355,715.26 | 5,005,163.92 | 3,958,279.72 | 4,020,220.68 |
| 一年内到期的非流动负债 | 3,185,825.71 | 3,222,502.69 | 3,378,329.49 | 3,569,467.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 124,552,074.1 | 146,953,945.86 | 150,050,297.04 | 141,860,569.69 |
| 非流动负债: | | | | |
| 租赁负债 | 5,092,014.52 | 5,830,727.82 | 6,565,496.09 | 7,639,873.09 |
| 递延收益 | 16,550,000 | 16,550,000 | 16,550,000 | 16,550,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 21,642,014.52 | 22,380,727.82 | 23,115,496.09 | 24,189,873.09 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 146,194,088.62 | 169,334,673.68 | 173,165,793.13 | 166,050,442.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 99,015,598 | 99,015,598 | 99,015,598 | 99,015,598 |
| 资本公积 | 2,586,519,065.43 | 2,582,971,327.53 | 2,576,785,811.7 | 2,570,584,394.63 |
| 其他综合收益 | -42,267.89 | -29,757.12 | 58,570.91 | 162,115.17 |
| 未分配利润 | -1,521,813,822.43 | -1,489,712,053.66 | -1,444,287,750.49 | -1,390,628,363.67 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,163,678,573.11 | 1,192,245,114.75 | 1,231,572,230.12 | 1,279,133,744.13 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,163,678,573.11 | 1,192,245,114.75 | 1,231,572,230.12 | 1,279,133,744.13 |
| 负债和股东权益合计 | 1,309,872,661.73 | 1,361,579,788.43 | 1,404,738,023.25 | 1,445,184,186.91 |
| 公告日期 | 2025-04-26 | 2025-04-19 | 2024-10-26 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |